PROM1 and neoplasm: This technique showed that CSV+ CD133− tumor cells have an EMT phenotype (i.e., express E-cadherin, Twist and Slug), and they act as CTSCs or metastatic CSCs, and also exhibit higher metastastatic properties compared with CSV- CD133+ cells [108].